| 000 | 01531 a2200385 4500 | ||
|---|---|---|---|
| 005 | 20250516112338.0 | ||
| 264 | 0 | _c20130426 | |
| 008 | 201304s 0 0 eng d | ||
| 022 | _a1569-8041 | ||
| 024 | 7 |
_a10.1093/annonc/mds299 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBraakhuis, B J M | |
| 245 | 0 | 0 |
_aTreatment choice for locally advanced head and neck cancers on the basis of risk factors: biological risk factors. _h[electronic resource] |
| 260 |
_bAnnals of oncology : official journal of the European Society for Medical Oncology _cSep 2012 |
||
| 300 |
_ax173-7 p. _bdigital |
||
| 500 | _aPublication Type: Congress; Overall | ||
| 650 | 0 | 4 |
_aAlphapapillomavirus _xpathogenicity |
| 650 | 0 | 4 |
_aCarcinoma, Squamous Cell _xdrug therapy |
| 650 | 0 | 4 |
_aCell Transformation, Neoplastic _xgenetics |
| 650 | 0 | 4 |
_aCisplatin _xtherapeutic use |
| 650 | 0 | 4 |
_aErbB Receptors _xgenetics |
| 650 | 0 | 4 |
_aHead and Neck Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMouth Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aNeoplasm Staging |
| 650 | 0 | 4 |
_aPapillomavirus Infections _xpathology |
| 650 | 0 | 4 | _aRecurrence |
| 650 | 0 | 4 | _aRisk Factors |
| 650 | 0 | 4 | _aSurvival Rate |
| 650 | 0 | 4 |
_aTumor Suppressor Protein p53 _xgenetics |
| 700 | 1 | _aBrakenhoff, R H | |
| 700 | 1 | _aLeemans, C René | |
| 773 | 0 |
_tAnnals of oncology : official journal of the European Society for Medical Oncology _gvol. 23 Suppl 10 _gp. x173-7 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1093/annonc/mds299 _zAvailable from publisher's website |
| 999 |
_c22113606 _d22113606 |
||